Form D — NextEvo, Inc.
0002053885-25-000002 · filed Jan 29, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $100,000
- Reported amount sold
- $100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NextEvo, Inc.
- CIK
- 2053885
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 181 WASHINGTON STREET
CONSHOHOCKEN, PA 19428 - Phone
- 925-200-6766
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John McDonagh · Executive OfficerConschohocken, PA Find on LinkedIn ↗
-
Gerry McNally · Executive OfficerConshohocken, PA Find on LinkedIn ↗
-
Edward H. Goodwin, III · DirectorConshohocken, PA Find on LinkedIn ↗
-
Cornelius Merlini · DirectorConshohocken, PA Find on LinkedIn ↗
-
Gerald Stahlecker · DirectorConshohocken, PA Find on LinkedIn ↗
-
William McComb · DirectorConshohocken, PA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗